{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:50:54Z","timestamp":1792515054166,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Relapsing polychondritis (RP) as a rare autoimmune disease is characterized by recurrent inflammation of the organs containing cartilage. Currently, no biomarkers have been integrated into clinical practice. This study aimed to construct and evaluate models based on laboratory parameters to aid in RP diagnosis, assess activity assessment, and explore associations with the pathological process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>RP patients and healthy controls (HCs) were recruited at the Peking Union Medical College Hospital from July 2017 to July 2023. Clinical data including Relapsing Polychondritis Disease Activity Index (RPDAI) score and laboratory tests were collected. Differences in laboratory data between RP patients and HCs and active and inactive patients were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The discovery cohort (cohort 1) consisted of 78 RP patients and 94 HCs. A model based on monocyte counts and neutrophil to lymphocyte ratio (NLR) could effectively distinguish RP patients from HCs with an AUC of 0.845. Active RP patients exhibited increased erythrocyte sedimentation rate, complement 3, platelet to lymphocyte ratio (PLR), NLR, and C-reactive protein to albumin ratio (CAR) compared with stable patients, which were also positively correlated with RPDAI. Notably, CAR emerged as an independent risk factor of disease activity (OR = 4.422) and could identify active patients with an AUC of 0.758. To confirm the reliability and stability of the aforementioned models, a replication cohort (cohort 2) was enrolled, including 79 RP patients and 94 HCs. The monocyte-combined NLR and CAR showed a sensitivity of 0.886 and 0.577 and a specificity of 0.830 and 0.833 in RP diagnosis and activity prediction, respectively. Furthermore, lower natural killer cell levels in RP patients and higher B-cell levels in active patients may contribute to elucidating the pathological mechanisms of disease occurrence and exacerbation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The utilization of laboratory parameters provides cost-effective and valuable markers that can assist in RP diagnosis, identify disease activity, and elucidate pathogenic mechanisms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1274677","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:41:09Z","timestamp":1696326069000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Development and validation of diagnostic and activity-assessing models for relapsing polychondritis based on laboratory parameters"],"prefix":"10.3389","volume":"14","author":[{"given":"Yongmei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoting","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev240","article-title":"Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study","volume":"54","author":"Hazra","year":"2015","journal-title":"Rheumatol (Oxford) [Journal Article; Res Support Non-U.S. Gov\u2019t]."},{"key":"B2","doi-asserted-by":"publisher","first-page":"102353","DOI":"10.1016\/j.autrev.2019.102353","article-title":"Tracheobronchial involvement of relapsing polychondritis","volume":"18","author":"de Montmollin","year":"2019","journal-title":"AUTOIMMUN Rev [Journal Article; Review]."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S121272","article-title":"Prevalence and comorbidity of relapsing polychondritis","volume":"8","author":"Ludvigsson","year":"2016","journal-title":"Clin EPIDEMIOL [Editorial]"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S91439","article-title":"A nationwide study of the epidemiology of relapsing polychondritis","volume":"8","author":"Horvath","year":"2016","journal-title":"Clin EPIDEMIOL [Journal Article]"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3449-8","article-title":"Clinical and prognostic characteristics of 158 cases of relapsing polychondritis in China and review of the literature","volume":"36","author":"Lin","year":"2016","journal-title":"RHEUMATOL Int [Journal Article; Review]."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2021.1979873","article-title":"Relapsing polychondritis: state-of-the-art review with three case presentations","volume":"133","author":"Grygiel-Gorniak","year":"2021","journal-title":"POSTGRAD Med [Case Reports; J Article; Review]."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.852854","article-title":"Serum level of soluble triggering receptor expressed on myeloid cells-1 as a biomarker of disease activity in relapsing polychondritis","volume":"24","author":"Sato","year":"2014","journal-title":"MOD Rheumatol [Journal Article; Res Support Non-U.S. Gov\u2019t]."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11301","article-title":"Serum MMP3 correlated with IL1beta messenger RNA expressions of peripheral blood mononuclear cells in patients with relapsing polychondritis with respiratory involvement","volume":"3","author":"Shimizu","year":"2021","journal-title":"ACR Open Rheumatol [Journal Article]"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200110)44:10<2402::AID-ART405>3.0.CO;2-L","article-title":"The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis","volume":"44","author":"Hansson","year":"2001","journal-title":"Arthritis Rheumatol [Journal Article; Res Support Non-U.S. Gov\u2019t]."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa225","article-title":"Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus","volume":"59","author":"Lopez","year":"2020","journal-title":"Rheumatol (Oxford) [Journal Article; Res Support Non-U.S. Gov\u2019t]."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05397-6","article-title":"Variation of red blood cell parameters in Behcet\u2019s disease: association with disease severity and vascular involvement","volume":"40","author":"Cheng","year":"2021","journal-title":"Clin Rheumatol [Journal Article]"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700224","article-title":"High neutrophil-to-lymphocyte ratio is an independent risk factor for end stage renal diseases in igA nephropathy","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol [Journal Article]"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa899","article-title":"Adult-onset Still\u2019s disease with neurological involvement: a single-centre report","volume":"60","author":"Zhao","year":"2021","journal-title":"Rheumatol (Oxford) [Journal Article; Res Support Non-U.S. Gov\u2019t]."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05827-z","article-title":"Three new inflammatory markers C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio correlated with relapsing polychondritis disease activity index","volume":"40","author":"Cao","year":"2021","journal-title":"Clin Rheumatol [Journal Article]"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-1-74","article-title":"Relapsing polychondritis. Survival and predictive role of early disease manifestations","volume":"104","author":"Michet","year":"1986","journal-title":"Ann Intern Med [Journal Article]"},{"key":"B16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","article-title":"Relapsing polychondritis: prospective study of 23 patients and a review of the literature","volume":"55","author":"McAdam","year":"1976","journal-title":"Med (Baltimore) [Case Reports; J Article; Res Support U.S. Gov\u2019t P.H.S.; Review]"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-197906000-00009","article-title":"Relapsing polychondritis\u2013report of ten cases","volume":"89","author":"Damiani","year":"1979","journal-title":"LARYNGOSCOPE. [Journal Article]"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.06.005","article-title":"The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis","volume":"12","author":"Arnaud","year":"2012","journal-title":"AUTOIMMUN Rev [Journal Article; Res Support Non-U.S. Gov\u2019t; Review]."},{"key":"B19","article-title":"Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis","volume":"28","author":"Kempta","year":"2010","journal-title":"Clin Exp Rheumatol [Journal Article]"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2004.09.012","article-title":"A case of relapsing polychondritis preceded by inner ear involvement","volume":"32","author":"Kumakiri","year":"2005","journal-title":"AURIS NASUS LARYNX [Case Reports; J Article]"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu147","article-title":"Utility of fluorodeoxyglucose positron emission tomography\/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: a case series and literature review","volume":"53","author":"Yamashita","year":"2014","journal-title":"Rheumatol (Oxford) [Case Reports; J Article; Res Support Non-U.S. Gov\u2019t; Review]."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med [Journal Article; Res Support N.I.H. Intramural; Res Support Non-U.S. Gov\u2019t]."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheumatol [Journal Article; Res Support N.I.H. Extramural; Res Support N.I.H. Intramural; Res Support Non-U.S. Gov\u2019t]."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.20613","article-title":"Serum cytokine profiles in relapsing polychondritis suggest monocyte\/macrophage activation","volume":"50","author":"Stabler","year":"2004","journal-title":"Arthritis Rheumatol [Journal Article; Res Support U.S. Gov\u2019t P.H.S.]"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/000348940111001108","article-title":"Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener\u2019s granulomatosis and relapsing polychondritis","volume":"110","author":"Ohwatari","year":"2001","journal-title":"Ann Otol Rhinol Laryngol [Journal Article; Res Support Non-U.S. Gov\u2019t]."},{"key":"B26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2249.2004.02471.x","article-title":"Immunoregulatory defects of V alpha 24V+ beta 11+ NKT cells in development of Wegener\u2019s granulomatosis and relapsing polychondritis","volume":"136","author":"Takagi","year":"2004","journal-title":"Clin Exp Immunol [Journal Article; Res Support Non-U.S. Gov\u2019t; Res Support U.S. Gov\u2019t P.H.S.]"},{"key":"B27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13075-022-02731-y","article-title":"Increased oxidative stress contributes to impaired peripheral CD56(dim)CD57(+) NK cells from patients with systemic lupus erythematosus","volume":"24","author":"Lu","year":"2022","journal-title":"Arthritis Res Ther [Journal Article; Res Support Non-U.S. Gov\u2019t]."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197811302992202","article-title":"Antibodies to type II collagen in relapsing polychondritis","volume":"299","author":"Foidart","year":"1978","journal-title":"N Engl J Med [Journal Article]"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/ard.40.5.473","article-title":"Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases","volume":"40","author":"Ebringer","year":"1981","journal-title":"Ann RHEUM Dis [Journal Article]"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709666","article-title":"Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia","volume":"67","author":"Shirota","year":"1993","journal-title":"Ann Hematol [Case Reports; J Article]"},{"key":"B31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0046-8177(80)80101-8","article-title":"Relapsing polychondritis. Immunomicroscopic findings in cartilage of ear biopsy specimens","volume":"11","author":"Valenzuela","year":"1980","journal-title":"Hum Pathol [Case Reports; J Article]"},{"key":"B32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/archderm.1978.01640130085034","article-title":"Relapsing polychondritis with positive direct immunofluorescence","volume":"114","author":"Bergfeld","year":"1978","journal-title":"Arch Dermatol [Case Reports; Letter]"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63183-5","article-title":"Relapsing polychondritis, induced in mice with matrilin 1, is an antibody- and complement-dependent disease","volume":"164","author":"Hansson","year":"2004","journal-title":"Am J Pathol [Journal Article; Res Support Non-U.S. Gov\u2019t]."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.912495","article-title":"The C-reactive protein\/albumin ratio and complete blood count parameters as indicators of disease activity in patients with takayasu arteritis","volume":"25","author":"Seringec","year":"2019","journal-title":"Med Sci Monit [Journal Article]"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(17)60007-9","article-title":"Predictive value of C-reactive protein\/albumin ratio in acute pancreatitis","volume":"16","author":"Kaplan","year":"2017","journal-title":"Hepatobil Pancreat Dis Int [Journal Article]"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.19.13625-5","article-title":"Prognostic value of C-reactive protein\/albumin ratio in neurocritically ill patients","volume":"85","author":"Bai","year":"2019","journal-title":"MINERVA ANESTESIOL [Journal Article]"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1274677\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:41:17Z","timestamp":1696326077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1274677\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2023.1274677"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1274677","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"article-number":"1274677"}}